Bora CDMO Bora CDMO

X

Find Dodecafluoropentane manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

MolPort-001-776-506
Also known as: Perflenapent, Perfluoropentane, 678-26-2, Perfluoro-n-pentane, Pentane, dodecafluoro-, Nvx-108
Molecular Formula
C5F12
Molecular Weight
288.03  g/mol
InChI Key
NJCBUSHGCBERSK-UHFFFAOYSA-N
FDA UNII
483AU1Y5CZ

Dodecafluoropentane is an ingredient in the EMA-withdrawn product EchoGen.
1 2D Structure

MolPort-001-776-506

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane
2.1.2 InChI
InChI=1S/C5F12/c6-1(7,2(8,9)4(12,13)14)3(10,11)5(15,16)17
2.1.3 InChI Key
NJCBUSHGCBERSK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F
2.2 Other Identifiers
2.2.1 UNII
483AU1Y5CZ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane

2. 1,1,1,2,2,3,4,5,5,5-decafluoropentane

3. 1,1,1,2,3,4,4,5,5,5-decafluoropentane

4. 2,3-dihydroperfluoropentane

5. 2h,3h-perfluoropentane

6. Echogen

7. Nvx-108

8. Perflenapent

9. Perfluoropentane

2.3.2 Depositor-Supplied Synonyms

1. Perflenapent

2. Perfluoropentane

3. 678-26-2

4. Perfluoro-n-pentane

5. Pentane, Dodecafluoro-

6. Nvx-108

7. N-perfluoropentane

8. 483au1y5cz

9. Chebi:39428

10. Perfluoropentane; Dodecafluoropentane

11. 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane

12. Perfuoro-n-pentane

13. Ncgc00167420-01

14. Flutec Pp50

15. Perflenapent [usan]

16. Mfcd00042081

17. Einecs 211-647-5

18. Perflenapent [usan:inn]

19. Brn 1712388

20. Perflenapentum

21. Unii-483au1y5cz

22. Dodecafluoro-pentane

23. R 41(12)

24. Fluorinert Fc 87

25. Fluorinertr(fc-87)

26. Dodecafluoro-n-pentane

27. Dodecafluoropentane(s)

28. Flutec Pp 50

29. Perfluoropentane 99%

30. Fluorinert Pf 5050

31. Perflenapent (usan/inn)

32. Perflenapent [inn]

33. Dsstox_cid_26613

34. Dsstox_rid_81766

35. Dsstox_gsid_46613

36. Schembl33962

37. Perflenapent [mart.]

38. 4-01-00-00308 (beilstein Handbook Reference)

39. Perflenapent [who-dd]

40. Chembl1899801

41. Dtxsid3046613

42. Nvx 108

43. Fc 87

44. Moli000988

45. Zinc8214647

46. Tox21_112424

47. Dodecafluoropentane [ema Epar]

48. Akos025310445

49. Db11625

50. Fc 4112

51. Cas-678-26-2

52. D05436

53. A835897

54. Q7168152

55. W-109591

56. 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane #

57. Pentane, 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoro-

58. 1,1,1,2,2,3,3,4,4,5,5,5-dodecakis(fluoranyl)pentane

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 288.03 g/mol
Molecular Formula C5F12
XLogP34.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count12
Rotatable Bond Count2
Exact Mass287.9808379 g/mol
Monoisotopic Mass287.9808379 g/mol
Topological Polar Surface Area0 Ų
Heavy Atom Count17
Formal Charge0
Complexity250
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

EchoGen is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left ventricular border delineation with resulting improvement in wall motion visualisation.

EchoGen should only be used in patients where the study without contrast enhancement is inconclusive.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Contrast Media

Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)


5.2 ATC Code

V08DA


V - Various

V08 - Contrast media

V08D - Ultrasound contrast media

V08DA - Ultrasound contrast media

V08DA03 - Perflenapent


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY